Cherry Research Committee   Report issue

Foundation Phase 2 Phase 4
Founded: DeWitt MI United States

Organization Overview

First Clinical Trial
2010
NCT01073982
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Cherry Research Committee

Active Ingredients

Drugs in Phase 4 Trials (1)

montmorency cherry (2 trials)

Drugs in Phase 2 Trials (1)

tart cherry (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiovascular Diseases (Phase 2)

Inflammation (Phase 4)

Metabolic Syndrome (Phase 2)

Osteoarthritis (Phase 4)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 2